March 26, 2024
A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas, the most deadly form of brain tumors.
April 12, 2024
University of Cincinnati researchers will present abstracts at the American Academy of Neurology annual meeting 2024, April 13-18 in Denver, Colorado.
May 26, 2023
The University of Cincinnati's Achala Vagal presented the results of the first large-scale assessment of radiological brain health in stroke patients in a population at the European Stroke Organization Conference 2023 in Munich, Germany.
September 15, 2022
The University of Cincinnati Gardner Neuroscience Institute is transforming into a Learning Health System, a data-driven, patient-centered approach with the goal of measurably improving outcomes for patients with neurological disorders.
August 27, 2021
UC research examining a music app to help breast cancer survivors is mentioned by Forbes.
March 15, 2021
University of Cincinnati researchers say for the first time they have a visual correlation between the severity of COVID-19 in the lungs and the effect on patients' brains, WVXU-FM reports.
March 12, 2021
For the first time, a visual correlation has been found between the severity of COVID-19 in the lungs using CT scans and the severity of effects on patient’s brains, using MRI scans, according to a new UC study.
April 16, 2021
Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.
June 3, 2022
The University of Cincinnati's Jensine' Clark and Emily Nurre lead transition clinics that help guide patients with childhood-onset disabilities and epilepsy from pediatric to adult care.
September 23, 2022
The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.